Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis

Patent No. EP3041476 (titled "Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis") was filed by Adare I on Sep 5, 2014. The application was issued on Jan 25, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DR FALK PHARMAJul 22, 2020LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3041476

ADARE I
Application Number
EP14842811A
Filing Date
Sep 5, 2014
Status
Patent Maintained As Amended
Dec 23, 2022
Publication Date
Jan 25, 2023